As of 2026-08-24, Linde plc Ordinary Share (LIN) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 1.8%, relative volume 0.96×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LIN is in a stage 1 base, week 5. Currently in a 36-day base; basing ADR 1.8% (broad 1.9%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -3.4% / 2.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
LIN is held by 2 ETFs as of Jun 2026. Top owner: PRCS at 3.19% weight, $5M notional.
Held by 210 ETFs · $29.8B across latest filings · largest weight 19.89% (IYM).
Top 2 by value, from SEC N-PORT-P filings dated Jun 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LIN Jan avg: 3.44% median: 4.01% win: 75% σ: 4.13% n: 4 2022-04-12 → 2026-07-31 | LIN Feb avg: 8.00% median: 8.07% win: 100% σ: 3.50% n: 4 2022-04-12 → 2026-07-31 | LIN Mar avg: 0.69% median: 0.86% win: 50% σ: 2.59% n: 4 2022-04-12 → 2026-07-31 | LIN Apr avg: -0.86% median: -1.64% win: 40% σ: 3.47% n: 5 2022-04-12 → 2026-07-31 | LIN May avg: 0.21% median: -0.69% win: 40% σ: 3.42% n: 5 2022-04-12 → 2026-07-31 | LIN Jun avg: 0.34% median: 0.76% win: 80% σ: 7.23% n: 5 2022-04-12 → 2026-07-31 | LIN Jul avg: 0.24% median: 2.52% win: 60% σ: 5.18% n: 5 2022-04-12 → 2026-07-31 | LIN Aug avg: 0.53% median: 1.49% win: 50% σ: 5.32% n: 4 2022-04-12 → 2026-07-31 (current) | LIN Sep avg: -2.37% median: -2.24% win: 0% σ: 2.20% n: 4 2022-04-12 → 2026-07-31 | LIN Oct avg: -0.84% median: -0.85% win: 50% σ: 9.51% n: 4 2022-04-12 → 2026-07-31 | LIN Nov avg: 5.15% median: 4.67% win: 75% σ: 6.84% n: 4 2022-04-12 → 2026-07-31 | LIN Dec avg: -2.27% median: -1.90% win: 25% σ: 5.45% n: 4 2022-04-12 → 2026-07-31 |